Physician

Nilay Desai, MD

According to 2025 Medicare claims, Nilay Desai, MD (NPI: 1336157122) practices endocrinology in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Nash, NC. This provider's primary affiliated billing organization is BOICE-WILLIS CLINIC PA (NPI: 1699722389; TIN: 561025986) and primary practice location at 27804-8467. Desai is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098), participating under the MSSP model.

Desai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 753 traditional Medicare patients, billed 7,935 HCPCS/CPT codes, and received $202,837 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,890 prescription claims across 1,091 beneficiaries totaling $2,976,565 in drug costs, led by Ozempic (Semaglutide). DME data shows 550 claims. Open Payments data shows 32 records totaling $18,279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $368,256 to $202,837. In contrast, Part D prescription costs have risen steadily, from $1,740,791 to $2,976,565. For DME billing, reported payments moved sharply higher in recent years, from $44,891 to $170,325.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,588	7,264	$368,256
2016	1,476	8,452	$339,973
2017	1,399	9,429	$317,357
2018	1,350	9,600	$311,724
2019	1,323	9,534	$286,408
2020	1,212	7,072	$245,143
2021	1,107	6,489	$241,629
2022	945	8,294	$218,666
2023	803	11,622	$230,300
2024	753	7,935	$202,837

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	954	6,168	$1,740,791
2016	873	5,620	$1,833,056
2017	824	5,291	$1,959,819
2018	837	5,444	$2,139,053
2019	846	5,017	$2,149,004
2020	931	5,762	$2,489,170
2021	975	6,281	$2,864,932
2022	967	5,744	$2,689,700
2023	1,031	6,463	$3,130,538
2024	1,091	6,890	$2,976,565

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	793	1,741	$76,077
2016	786	1,773	$77,169
2017	693	1,678	$82,839
2018	521	1,317	$92,667
2019	308	956	$90,188
2020	267	954	$128,114
2021	217	1,120	$180,669
2022	204	965	$159,009
2023	164	923	$164,727
2024	142	550	$166,606

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	600	848	$80
76536	Ultrasound scan of head and neck soft tissue	69	70	$45
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	118	281	$40
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	153	252	$23
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	416	521	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	465	21,978	$723,025
Jardiance	Empagliflozin	250	12,871	$255,518
Tresiba Flextouch U-200	Insulin Degludec	208	13,234	$197,021
Trulicity	Dulaglutide	121	5,164	$176,026
Mounjaro	Tirzepatide	103	3,674	$134,513

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	88	399	$153,537
E0784	External ambulatory infusion pump, insulin	Y	N/R	12	$4,193
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	16	$3,777
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	12	12	$2,601
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	15	$1,159

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$18,279	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nilay Desai, MD?

Tedicare shows public-source Medicare data for Nilay Desai, MD (NPI 1336157122), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nilay Desai, MD have ACO affiliation data?

Nilay Desai, MD is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098).

What billing organization is linked to Nilay Desai, MD?

Nilay Desai, MD is linked to BOICE-WILLIS CLINIC PA (billing NPI 1699722389) in the available physician profile data.

Does Nilay Desai, MD have Open Payments data?

Nilay Desai, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.